Development of a simple screening tool for opportunistic COPD case finding in primary care in Latin America: The PUMA study

Respirology

Volumn 21, Issue 7, 2016, Pages 1227-1234

  López Varela, Maria Victorina ^a   Montes de Oca, Maria ^b   Rey, Alejandra ^a   Casas, Alejandro ^c   Stirbulov, Roberto ^d   Di Boscio, Valentina ^e  

^a DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

^b HOSPITAL UNIVERSITARIO DE CARACAS   (Venezuela)

^c Pulmonary Function Laboratory   (Colombia)

^d FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^e ASTRAZENECA   (United Kingdom)

Author keywords

case finding; COPD; primary care; PUMA; screening score

Indexed keywords

ADULT; AGE; ARGENTINA; ARTICLE; CASE FINDING; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLOMBIA; COUGHING; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; POPULATION RISK; PREDICTIVE VALUE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PUMA SCORE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SMOKING; SPIROMETRY; SPUTUM; URUGUAY; VENEZUELA;

EID: 84987646023     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12834     Document Type: Article

References (35)

1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095–128.
2. Lopez-Campos JL, Ruiz-Ramos M, Soriano JB. Mortality trends in chronic obstructive pulmonary disease in Europe, 1994-2010: a joinpoint regression analysis. Lancet Respir. Med. 2014; 2: 54–62.
3. Rycroft CE, Heyes A, Lanza L, Becker K. Epidemiology of chronic obstructive pulmonary disease: a literature review. Int. J. Chron. Obstruct. Pulmon. Dis. 2012; 7: 457–94.
4. Ford ES, Croft JB, Mannino DM, Wheaton AG, Zhang X, Giles WH. COPD surveillance – United States, 1999–2011. Chest 2013; 144: 284–305.
5. Menezes AM, Perez-Padilla R, Jardim J, Muiño A, Lopez MV, Valdivia G, Montes de Oca M, Talamo C, Hallal PC, Victora CG. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005; 366: 1875–81.
6. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370: 715–6.
7. Soriano J, Ancochea J, Miravitlles M, García-Río F, Duran-Tauleria E, Muñoz L, Jiménez-Ruiz CA, Masa JF, Viejo JL, Villasante C et al. Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997–2007. Eur. Respir. J. 2010; 36: 758–65.
8. Talamo C, Montes de Oca M, Halbert R, Perez-Padilla R, Jardim JR, Muiño A, Valdivia G, Pertuzé J, Menezes AM, PLATINO team. Diagnostic labeling of chronic obstructive pulmonary disease in five Latin American Cities. Chest 2007; 131: 60–7.
9. Murphy DE, Panos RJ. Diagnosis of COPD and clinical course in patients with unrecognized airflow limitation. Int. J. Chron. Obstruct. Pulmon. Dis. 2013; 8: 199–208.
10. Montes de Oca M, Perez-Padilla R, Tálamo C, Halbert RJ, Moreno D, Lopez MV, Muiño A, José Roberto BJ, Valdivia G, Pertuzé J et al. PLATINO Team. Acute bronchodilator responsiveness in subjects with and without airflow obstruction in five Latin American cities: the PLATINO study. Pulm. Pharmacol. Ther. 2010; 23: 29–35.
11. Bednarek M, Maciejewski J, Wozniak M, Kuca P, Zielinski J. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax 2008; 63: 402–7.
12. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2013; 187: 347–65.
13. Montes de Oca M, López Varela MV, Acuña A, Schiavi E, Rey MA, Jardim J, Casas A, Tokumoto A, Torres Duque CA, Ramírez-Venegas A et al. Chronic Obstructive Pulmonary Disease (COPD) Clinical Practice Guidelines: Questions and Answers. Arch. Bronconeumol. 2015; 51: 403–6.
14. Konstantikaki V, Kostikas K, Minas M, Batavanis G, Daniil Z, Gourgoulianis KI, Hatzoglou C. Comparison of a network of primary care physicians and an open spirometry programme for COPD diagnosis. Respir. Med. 2011; 105: 274–81.
15. Haroon S, Adab P, Griffin C, Jordan R. Case finding for chronic obstructive pulmonary disease in primary care: a pilot randomised controlled trial. Br. J. Gen. Pract. 2013; 63: e55–62.
16. Tinkelman DG, Price D, Nordyke RJ, Halbert RJ. COPD screening efforts in primary care: what is the yield? Prim. Care Respir. J. 2007; 16: 41–8.
17. Vandevoorde J, Verbanck S, Gijssels L, Schuermans D, Devroey D, De Backer J, Kartounian J, Vincken W. Early detection of COPD: a case finding study in general practice. Respir. Med. 2007; 101: 525–30.
18. Ulrik CS, Løkke A, Dahl R, Dollerup J, Hansen G, Cording PH, Andersen KK, TOP study group. Early detection of COPD in general practice. Int. J. Chron. Obstruct. Pulmon. Dis. 2011; 6: 123–7.
19. Hill K, Goldstein RS, Guyatt GH, Blouin M, Tan WC, Davis LL, Heels-Ansdell DM, Erak M, Bragaglia PJ, Tamari IE et al. Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. CMAJ 2010; 182: 673–8.
20. Stratelis G, Jakobsson P, Molstad S, Zetterstrom O. Early detection of COPD in primary care: screening by invitation of smokers aged 40 to 55 years. Br. J. Gen. Pract. 2004; 54: 201–6.
21. Laniado-Laborin R, Rendon A, Bauerle O. Chronic obstructive pulmonary dis-ease case finding in Mexico in an at risk population. Int. J. Tuberc. Lung Dis. 2011; 15: 818–23.
22. Price DB, Tinkelman DG, Nordyke RJ, Isonaka S, Halbert RJ, COPD Questionnaire Study Group. Scoring system and clinical application of COPD diagnostic questionnaires. Chest 2006; 129: 1531–9.
23. Frith P, Crockett A, Beilby J, Marshall D, Attewell R, Ratnanesan A, Gavagna G. Simplified COPD screening: validation of the PiKo-6® in primary care. Prim. Care Respir. J. 2011; 20: 190–8.
24. Sichletidis L, Spyratos D, Papaioannou M, Chloros D, Tsiotsios A, Tsagaraki V, Haidich AB. A combination of the IPAG questionnaire and PiKo-6® flow meter is a valuable screening tool for COPD in the primary care setting. Prim. Care Respir. J. 2011; 20: 184–9.
25. Sims EJ, Price D. Spirometry: an essential tool for screening, case finding, and diagnosis of COPD. Prim. Care Respir. J. 2012; 21: 128–30.
26. Stanley AJ, Hasan I, Crockett AJ, van Schayck OC, Zwar NA. Validation of the COPD Diagnostic Questionnaire in an Australian general practice cohort: a cross-sectional study. Prim. Care Respir. J. 2014; 23: 92–7.
27. Schiavi E, Stirbulov R, Hernández Vecino R, Mercurio S, Di Boscio V, PUMA Team. COPD Screening in Primary Care in Four Latin American Countries: Methodology of the PUMA Study. Arch. Bronconeumol. 2014; 50: 469–74.
28. Dales RE, Aaron SD, Vandemheen KL, Mehdizadeh A, Clinch J. The prevalence of airflow obstruction in rural primary care. Respir. Med. 2006; 100: 754–9.
29. Fukahori S, Matsuse H, Takamura N, Hirose H, Tsuchida T, Kawano T, Fukushima C, Mizuta Y, Kohno S. Prevalence of chronic obstructive pulmonary diseases in general clinics in terms of FEV1/FVC. Int. J. Clin. Pract. 2009; 63: 269–74.
30. Kögler H, Metzdorf N, Glaab T, Welte T. Preselection of patients at risk for COPD by two simple screening questions. Respir. Med. 2010; 104: 1012–9.
31. Zielinski J, Bednarek M. Early detection of COPD in a high-risk population using spirometric screening. Chest 2001; 119: 731–6.
32. Ohar JA, Sadeghnejad A, Meyers DA, Donohue JF, Bleecker ER. Do symptoms predict COPD in smokers? Chest 2010; 137: 1345–53.
33. Thorn J, Tilling B, Lisspers K, Jörgensen L, Stenlin A, Stratelis G. Improved prediction of COPD in at-risk patients using lung function pre-screening in primary care: a real-life study and cost-effectiveness analysis. Prim. Care Respir. J. 2012; 21: 159–66.
34. Kotz D, Nelemans P, van Schayck CP, Wesseling GJ. External validation of a COPD diagnostic questionnaire. Eur. Respir. J. 2008; 31: 298–303.
35. Bergna MA, García GR, Alchapar R, Altieri H, Casas JC, Larrateguy L, Nannini LJ, Pascansky D, Grabre P, Zabert G et al. Development of a simple binary response questionnaire to identify airflow obstruction in a smoking population in Argentina. Eur. Respir. Rev. 2015; 24: 320–6.